Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial.
JAMA. 2021 Sep 14;326(10):916-925. doi: 10.1001/jama.2021.12836.
JAMA. 2021.
PMID: 34519801
Free PMC article.
Clinical Trial.